Double Blind Controlled Trial of an Extensively Hydrolyzed Formula With a Probiotic vs. an Extensively Hydrolyzed Formula Without a Probiotic
Study Details
Study Description
Brief Summary
The purpose of this study is to confirm the hypoallergenicity of an extensively hydrolyzed formula with an added probiotic in children with documented milk allergy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Extensively Hydrolyzed Formula with a Probiotic Extensively Hydrolyzed Formula with a Probiotic |
Other: Extensively Hydrolyzed Formula with a Probiotic
|
Placebo Comparator: Extensively Hydrolyzed Formula without a Probiotic
|
Other: Extensively Hydrolyzed Formula without a Probiotic
|
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
≤14 years of age
-
Essentially asymptomatic for a minimum of 7 days pre-challenge.
-
Successful previous consumption of Extensively Hydrolyzed Formula within 1 week of study enrollment
-
Medically documented allergy to cow's milk
Exclusion Criteria:
-
Presence of underlying systemic disease or other illness
-
Used Beta-blockers within 12-24 hours of challenges
-
Use of short-acting antihistamines within 3 days
-
Use of medium-acting antihistamines within 7 days
-
Use of long-acting antihistamines within 6 weeks
-
Use of oral steroid medication within 3 weeks
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Dept. of Paediatrics, Azienda Ospedaliera di Padova | Padova | Veneto | Italy | 35128 |
2 | Wilhelmina Children's Hospital | Utrecht | Netherlands | 3508 |
Sponsors and Collaborators
- Mead Johnson Nutrition
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 3369-2